fda banned semaglutide ban The FDA has removed semaglutide injection products (GLP-1) from the shortage list Novo pressures GLP-1 compounders as
Description
Fact Same active ingredient (semaglutide), different indications and prices
E., Bian, J., Guo, J., & Chen, Y
Patients should never take both medications simultaneously, as research on concurrent use remains limited
Side Effects of Injections In addition to the typical side effects of GLP-1s, such as constipation, nausea, bloating, vomiting, and diarrhea, injections have their own potential side effects
Both have finite shelf lives once reconstituted, typically 4 to 6 weeks refrigerated
